Furthermore, CHACR inhibited the Jak2/Stat3 pathway by regulating CPT1b expression, which may be involved in the pathogenesis of cardiac hypertrophy (Fig. 7C-E, S2). Here, JAK2 is linked to cardiac hypertrophy.